On Air Now
Early Breakfast with Jenni Falconer 4am - 6am
Actress Sheila Hancock has launched a 'Wall of Hope' to raise £1m for research at the Brain Tumour Research centre of excellence at the University of Portsmouth.
The wall marks the launch of Brain Tumour Research's national £7m 'Centres of Hope' fundraising campaign to raise £7m for seven centres of excellence to get seven times closer to a cure for brain tumours.
Sheila Hancock, whose grandson Jack was diagnosed with a brain tumour, is calling on local businesses, organisations and Portsmouth residents to help raise £1m to fund brain tumour research at the centre by sponsoring a day of research for £2,740, which will be recognised by a commemorative plaque on the centre's 'Wall of Hope' as well as on the website, www.braintumourresearch.org.
The centre, under the leadership of Professor Geoff Pilkington, is one of seven planned as part of Brain Tumour Research's 'Centres of Hope' campaign to address the serious under-funding of research into the UK's biggest cancer killer of children and adults under 40 .
In the UK, brain tumours kill more children than leukaemia or any other cancer; more women under the age of 35 than breast or any other cancer and more men under the age of 45 than prostate or any other cancer, yet brain tumour research receives less than 1% of national cancer research spending .
Actress, and Chancellor of the University of Portsmouth, Sheila Hancock says:
"My grandson Jack was diagnosed with a brain tumour at the age of four - we were incredibly lucky Jack's tumour was low grade and he lives a normal healthy life now, but it is terrible to watch a family member go through the diagnosis and treatment of a brain tumour. I implore you to get involved and buy as many days as you can on the 'Wall of Hope' to support vital research here at the University of Portsmouth's centre of excellence".
Geoff Pilkington, Professor of Cellular & Molecular Neuro-oncology at the University of Portsmouth says:
"Previous discoveries in the area of brain tumours have not translated into significant clinical progress because the lack of funding has prevented sustainable research. I strongly believe that what my colleagues and I are doing at the Portsmouth centre of excellence will eventually result in real benefit for the 16,000 patients diagnosed with brain tumours each year ."